Authors
Loading...
Observational analysis reveals DAA therapy's effectiveness in reducing HCC recurrence risk, highlighting potential implications for patient management.
Zarębska‐Michaluk et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: